Metis TechBio, a biotech company using AI to deliver and formulate drugs, surged as much as 185% in its Hong Kong market debut after raising ~$270M in its IPO (Amber Tong/Bloomberg)

Amber Tong / Bloomberg:
Metis TechBio, a biotech company using AI to deliver and formulate drugs, surged as much as 185% in its Hong Kong market debut after raising ~$270M in its IPO  —  Shares of Metis TechBio Co, a biotechnology company using artificial intelligence to deliver and formulate drugs …

Posted from: this blog via Microsoft Power Automate.

Daily Deals